Evidence map›Paper›PMID 23555015›Full record

ArticlePloS one2013

Rab GTPases regulate endothelial cell protein C receptor-mediated endocytosis and trafficking of factor VIIa.

Ramesh C Nayak, Shiva Keshava, Charles T Esmon, Usha R Pendurthi, L Vijaya Mohan Rao

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Development of a Neuroprotective Erythropoietin Modified with a Novel Carrier for the Blood-Brain Barrier.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ramesh C NayakDepartment of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Shiva Keshava
Charles T Esmon
Usha R Pendurthi
L Vijaya Mohan Rao
The University of Texas Health Science Center at Tyler · USOklahoma Medical Research Foundation · US

Funding

Factor VIIa Interaction with Endothelial Cell Protein C ReceptorR01HL107483 · NHLBI · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI LELLA, VIJAYA MOHAN RAO · 2012 to 2019
$2.9M
INITIATION AND REGULATION OF BLOOD COAGULATIONR01HL058869 · NHLBI · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI LELLA, VIJAYA MOHAN RAO · 1998 to 2010
$2.3M
Howard Hughes Medical InstituteNHLBI NIH HHS HL107483NHLBI NIH HHS HL58869NHLBI NIH HHS R01 HL058869NHLBI NIH HHS R01 HL107483
6 · The paper itself

Abstract

Recent studies have established that factor VIIa (FVIIa) binds to the endothelial cell protein C receptor (EPCR). FVIIa binding to EPCR may promote the endocytosis of this receptor/ligand complex. Rab GTPases are known to play a crucial role in the endocytic and exocytic pathways of receptors or receptor/ligand complexes. The present study was undertaken to investigate the role of Rab GTPases in the intracellular trafficking of EPCR and FVIIa. CHO-EPCR cells and human umbilical vein endothelial cells (HUVEC) were transduced with recombinant adenoviral vectors to express wild-type, constitutively active, or dominant negative mutant of various Rab GTPases. Cells were exposed to FVIIa conjugated with AF488 fluorescent probe (AF488-FVIIa), and intracellular trafficking of FVIIa, EPCR, and Rab proteins was evaluated by immunofluorescence confocal microscopy. In cells expressing wild-type or constitutively active Rab4A, internalized AF488-FVIIa accumulated in early/sorting endosomes and its entry into the recycling endosomal compartment (REC) was inhibited. Expression of constitutively active Rab5A induced large endosomal structures beneath the plasma membrane where EPCR and FVIIa accumulated. Dominant negative Rab5A inhibited the endocytosis of EPCR-FVIIa. Expression of constitutively active Rab11 resulted in retention of accumulated AF488-FVIIa in the REC, whereas expression of a dominant negative form of Rab11 led to accumulation of internalized FVIIa in the cytoplasm and prevented entry of internalized FVIIa into the REC. Expression of dominant negative Rab11 also inhibited the transport of FVIIa across the endothelium. Overall our data show that Rab GTPases regulate the internalization and intracellular trafficking of EPCR-FVIIa.

Indexed as

AdenoviridaeAnimalsAntigens, CDCHO CellsCricetinaeEndocytosisEndothelial Protein C ReceptorFactor VIIaFluorescent DyesGene Expression RegulationHumansHuman Umbilical Vein Endothelial CellsProtein Transportrab11 GTP-Binding Proteinsrab4 GTP-Binding Proteinsrab5 GTP-Binding ProteinsAntigens, CDEndothelial Protein C ReceptorFactor VIIaFluorescent DyesPROCR protein, humanrab11 GTP-Binding Proteinsrab4 GTP-Binding Proteinsrab5 GTP-Binding Proteinsrab GTP-Binding ProteinsReceptors, Cell Surface

Identifiers

PMID23555015
PMCPMC3598704
OpenAlexW1994290150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.